Diane Daych

DianeDaych.jpg

Diane M. Daych is a Partner at Apple Tree Partners. She has over 25 years of investing, advisory and operating experience, with over 20 years focused on the healthcare services industry. She joined Apple Tree Partners in 2013 to lead their healthcare services investing.

From 2010 to 2012, she was a Managing Director and Co-Head, Private Equity of the Marwood Group. Additionally, since 2000, Diane has been a partner and principal at CCP Equity Partners (“CCP”) and its predecessor firm, Conning Capital Partners, where she invested in growth companies that offer specialized solutions for the financing, management and delivery of health care in industries such as managed care, disease and care management, outpatient services, information technology and healthcare-related ancillary and outsourcing services.

Prior to joining CCP in 2000, she held a senior development role at Mariner Health, a post acute care company, where she worked with operating management to develop the strategies and structures for physician practice management acquisitions and joint ventures. Prior to Mariner, Diane held senior operating roles at Medical Care America (MCA), one of the largest operators of free standing ambulatory surgery centers at that time.

Diane currently sits on the Board of directors of TripleCare, CleanSlate Addiction Treatment Centers, QualDerm Partners, Prism Education Group, the Tuck School’s MBA Advisory Board and The Healthcare Private Equity Association (HCPEA). She was previously on the Board of directors of Cogent Healthcare, Relay Health, Zoologic and an observer for Evolution Benefits and Vantage Oncology. She also previously sat on the Board of directors of the Women’s Association of Venture and Equity (WAVE), and she is a past president of the Hartford Chapter of the Connecticut Venture Group and sat on its statewide Board for several years. She received an MBA from the Tuck School at Dartmouth College and a BA in Economics from Lehigh University.

MEDIA ABOUT DIANE DAYCH

http://www.ambulatoryadvisor.com/financial-sponsors924/(24Sept14)

TAG: Fund's investment verticals: pharmaceuticals, biotech, MedTech, and healthcare service.